Human melanoma cells under endoplasmic reticulum stress acquire resistance to microtubule-targeting drugs through XBP-1-mediated activation of akt

Neoplasia

Volumn 11, Issue 5, 2009, Pages 436-447

  Jiang, Chen Chen ^a   Yang, Fan ^a   Thorne, Rick F ^a   Zhu, Bi Ke ^a   Hersey, Peter ^a,b   Zhang, Xu Dong ^a  

^a CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ACTIVATING TRANSCRIPTION FACTOR 6; DOCETAXEL; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAK; PROTEIN BAX; PROTEIN IRE1; PROTEIN IRE1 ALPHA; PROTEIN KINASE B; SMALL INTERFERING RNA; THAPSIGARGIN; TUNICAMYCIN; UNCLASSIFIED DRUG; VINCRISTINE; X BOX BINDING PROTEIN 1;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; DRUG RESPONSE; DRUG TARGETING; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; MELANOMA CELL; MICROTUBULE; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN SECRETION; SIGNAL TRANSDUCTION;

EID: 65949106608     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.09208     Document Type: Article

References (47)

1. Soengas MS and Lowe SW (2003). Apoptosis and melanoma chemoresistance. Oncogene 22, 3138-3151.
2. Hersey P, Zhuang L, and Zhang XD (2006). Current strategies in overcoming resistance of cancer cells to apoptosis melanoma as a model. Int Rev Cytol 251, 131-158.
3. Harding HP, Calfon M, Urano F, Novoa I, and Ron D (2002). Transcriptional and translational control in the mammalian unfolded protein response. Annu Rev Cell Dev Biol 18, 575-599.
4. Zhang K and Kaufman RJ (2004). Signaling the unfolded protein response from the endoplasmic reticulum. J Biol Chem 279, 25935-25938.
5. Schroder M and Kaufman RJ (2005). The mammalian unfolded protein re- sponse. Annu Rev Biochem 74, 739-789.
6. Lee AS (2007). GRP78 induction in cancer: therapeutic and prognostic impli- cations. Cancer Res 67, 3496-3499.
7. Ma Y and Hendershot LM (2004). The role of the unfolded protein response in tumour development: friend or foe? Nat Rev Cancer 4, 966-977.
8. Hersey P and Zhang XD (2008). Adaptation to ER stress as a driver of malig- nancy and resistance to therapy in human melanoma. Pigment Cell Melanoma Res 21, 358-367.
9. Zhuang L, Lee CS, Scolyer RA, McCarthy SW, Zhang XD, Thompson JF, and Hersey P (2009). Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma. Histopathology. DOI: 10:1111/J.1365-2559.
10. Jiang CC, Mao ZG, Avery-Kiejda KA, Wade M, Hersey P, and Zhang XD (2009). Glucose-regulated protein 78 antagonizes cisplatin and adriamycin in human melanoma cells. Carcinogenesis 30, 197-204.
11. Li J and Lee AS (2006). Stress induction of GRP78/BiP and its role in cancer. Curr Mol Med 6,45-54.
12. Denoyelle C, Abou-Rjaily G, Bezrookove V, Verhaegen M, Johnson TM, Fullen DR, Pointer JN, Gruber SB, Su LD, Nikiforov MA, et al. (2006). Anti- oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nat Cell Biol 8,1053-1063.
13. Ferri KF and Kroemer G (2001). Organelle-specific initiation of cell death path- ways. Nat Cell Biol 3, E255-E263.
14. Boyce M and Yuan J (2006). Cellular response to endoplasmic reticulum stress: a matter of life or death. Cell Death Differ 13, 363-373.
15. Hitomi J, Katayama T, Eguchi Y, Kudo T, Taniguchi M, Koyama Y, Manabe T, Yamagishi S, Bando Y, Imaizumi K, et al. (2004). Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Abeta-induced cell death. J Cell Biol 165, 347-356.
16. Xu C, Bailly-Maitre B, and Reed JC (2005). Endoplasmic reticulum stress: cell life and death decisions. J Clin Invest 115, 2656-2664.
17. Jiang CC, Lucas K, Avery-Kiejda KA, Wade M, deBock CE, Thorne RF, Allen J, Hersey P, and Zhang XD (2008). Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress. Cancer Res 68, 6708-6717.
18. Koong AC, Chauhan V, and Romero-Ramirez L (2006). Targeting XBP-1 as a novel anti-cancer strategy. Cancer Biol Ther 5, 756-759.
19. Zhang XD, Franco A, Myers K, Gray C, Nguyen T, and Hersey P (1999). Re- lation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE inhibitory protein expression to TRAIL-induced apoptosis of melanoma. Cancer Res 59, 2747-2753.
20. Wang YF, Jiang CC, Kiejda KA, Gillespie S, Zhang XD, and Hersey P (2007). Apoptosis induction in human melanoma cells by inhibition of MEK is caspase- independent and mediated by the Bcl-2 family members PUMA, Bim, and Mcl-1. Clin Cancer Res 13, 4934-4942.
21. Jiang CC, Chen LH, Gillespie S, Wang YF, Kiejda KA, Zhang XD, and Hersey P (2007). Inhibition of MEK/ERK sensitizes human melanoma cells to endoplasmic reticulum stress-induced apoptosis by enhancing caspase-4 activation. Cancer Res 67, 9750-9761.
22. Elbein AD (1987). Inhibitors of the biosynthesis and processing of N -linked oligosaccharide chains. Annu Rev Biochem 56, 497-534.
23. 2+transport ATPase by thapsigargin at subnanomolar concentrations. J Biol Chem 266, 13503-13506.
24. Mhaidat NM, Zhang XD, Jiang CC, and Hersey P (2007). Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal- regulated kinase 1/2 pathway. Clin Cancer Res 13,1308-1314.
25. Zhu BK, Wang P, Zhang XD, Jiang CC, Chen LH, Avery-Kiejda KA, Watts R, and Hersey P (2008). Activation of Jun N-terminal kinase is a mediator of vincristine- induced apoptosis of melanoma cells. Anticancer Drugs 19, 189-200.
26. L, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 19, 1294-1305.
27. Stahl JM, Sharma A, Cheung M, Zimmerman M, Cheng JQ, Bosenberg MW, Kester M, Sandirasegarane L, and Robertson GP (2004). Deregulated Akt3 activity promotes development of malignant melanoma. Cancer Res 64,7002-7010.
28. Lovat PE, Corazzari M, Armstrong JL, Martin S, Pagliarini V, Hill D, Brown AM, Piacentini M, Birch-Machin MA, and Redfern CP (2008). Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival re- sponses to endoplasmic reticulum stress. Cancer Res 68,5363-5369.
29. INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumors. Neoplasia 10, 1231-1239.
30. Hu P, Han Z, Couvillon AD, and Exton JH (2004). Critical role of endogenous Akt/IAPs and MEK1/ERK pathways in counteracting endoplasmic reticulum stress-induced cell death. J Biol Chem 279, 49420-49429.
31. Bonilla M, Nastase KK, and Cunningham KW (2002). Essential role of calcineurin in response to endoplasmic reticulum stress. EMBO J 21, 2343-2353.
32. Pérez-García MJ, Ceña V, de Pablo Y, Llovera M, Comella JX, and Soler RM (2004). Glial cell line-derived neurotrophic factor increases intracellular calcium concentration. Role of calcium/calmodulin in the activation of the phosphatidyl- inositol 3-kinase pathway. J Biol Chem 279,6132-6142.
33. Matthews JA, Belof JL, Acevedo-Duncan M, and Potter RL (2007). Glucosamine- induced increase in Akt phosphorylation corresponds to increased endoplasmic re- ticulum stress in astroglial cells. Mol Cell Biochem 298, 109-123.
34. Hu MC, Gong HY, Lin GH, Hu SY, Chen MH, Huang SJ, Liao CF, and Wu JL (2007). A key regulator of unfolded protein response, activates transcription of IGF1 and Akt phosphorylation in zebrafish embryonic cell line. Biochem Biophys Res Commun 359,778-783.
35. Lee JT, Brafford P, and Herlyn M (2008). Unraveling the mysteries of IGF-1 signaling in melanoma. J Invest Dermatol 128, 1358-1360.
36. Rodeck U, Melber K, Kath R, Menssen HD, Varello M, Atkinson B, and Herlyn M (1991). Constitutive expression of multiple growth factor genes by melanoma cells but not normal melanocytes. J Invest Dermatol 97,20-26.
37. Nishitoh H, Matsuzawa A, Tobiume K, Saegusa K, Takeda K, Inoue K, Hori S, Kakizuka A, and Ichijo H (2002). ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev 16, 1345-1355.
38. Matsuura H, Nishitoh H, Takeda K, Matsuzawa A, Amagasa T, Ito M, Yoshioka K, and Ichijo H (2002). Phosphorylation-dependent scaffolding role of JSAP1/JIP3 in the ASK1-JNK signaling pathway. A new mode of regulation of the MAP kinase cascade. J Biol Chem 277, 40703-40709.
39. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, and Greenberg ME (1999). Cell survival promoted by the Ras-MAPK signaling pathway by transcription- dependent and -independent mechanisms. Science 286,1358-1362.
40. Wendel HG, De Stanchina E, Fridman JS, Malina A, Ray S, Kogan S, Cordon- Cardo C, Pelletier J, and Lowe SW (2004). Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 428, 332-337.
41. +/- mice. Neoplasia 10, 866-872.
42. Wang JM, Chao JR, Chen W, Kuo ML, Yen JJ, and Yang-Yen HF (1999). The antiapoptotic gene mcl-1 is up-regulated by the phosphatidylinositol 3-kinase/Akt signaling pathway through a transcription factor complex containing CREB. Mol Cell Biol 19,6195-6206.
43. Kuo ML, Chuang SE, Lin MT, and Yang SY (2001). The involvement of PI 3-K/Akt-dependent up-regulation of Mcl-1 in the prevention of apoptosis of Hep3B cells by interleukin-6. Oncogene 20, 677-685.
44. Mei Y, Xie C, Xie W, Tian X, Li M, and Wu M (2007). Noxa/Mcl-1 balance regulates susceptibility of cells to camptothecin-induced apoptosis. Neoplasia 9, 871-881.
45. Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG, Colman PM, Day CL, Adams JM, and Huang DC (2005). Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic func- tion. Mol Cell 17, 393-403.
46. Joo JH, Liao G, Collins JB, Grissom SF, and Jetten AM. (2007).Farnesol- induced apoptosis in human lung carcinoma cells is coupled to the endoplasmic reticulum stress response. Cancer Res 67, 7929-7936.
47. Liao PC, Tan SK, Lieu CH, and Jung HK (2008). Involvement of endoplasmic reticulum in paclitaxel-induced apoptosis. J Cell Biochem 104, 1509-1523.